
Opinion|Videos|December 5, 2025
Payer and Prior Authorization Barriers
Panelists discuss how payer controls and prior authorization policies delay and derail LDL-lowering therapy.
Advertisement
Episodes in this series

Panelists discuss how payer utilization management and prior authorization processes delay therapy initiation and contribute to high abandonment rates.
The paperwork burden discourages prescribers and frustrates patients, often interrupting continuity of care. Panelists highlight that these barriers disproportionately affect lower-income populations and smaller practices.
They recommend policy reforms that balance cost control with clinical flexibility, enabling timely treatment for high-risk individuals.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Obesity, Insulin Resistance, and the Silent Progression of MASH: A Hepatologist's Perspective
3
Fifth Death Confirmed in NYC Legionnaires' Outbreak
4
How Portable Oxygen Is Changing Home Respiratory Care: Doug Francis
5





